Association of the germline TP53 R337H mutation with breast cancer in southern Brazil (Q33388533)

26 July 2017

title

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil (English)

1 reference

Erratum to: Association of the germline TP53 R337H mutation with breast cancer in southern Brazil

26 July 2017

0 references

corrigendum / erratum

1 reference

DOI

10.1186/1471-2407-11-152

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1186/1471-2407-11-152

author name string

Juliana G Assumpção

1

1 reference

26 July 2017

Ana Luíza Seidinger

2

1 reference

26 July 2017

Maria José Mastellaro

3

1 reference

26 July 2017

Raul C Ribeiro

4

1 reference

26 July 2017

Gerard P Zambetti

5

1 reference

26 July 2017

Ramapriya Ganti

6

1 reference

26 July 2017

Kumar Srivastava

7

1 reference

26 July 2017

Sheila Shurtleff

8

1 reference

26 July 2017

Deqing Pei

9

1 reference

26 July 2017

Luiz Carlos Zeferino

10

1 reference

26 July 2017

Rozany M Dufloth

11

1 reference

26 July 2017

Silvia Regina Brandalise

12

1 reference

26 July 2017

José Andres Yunes

13

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

8

1 reference

26 July 2017

page(s)

357

1 reference

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

The p53 mutation "gradient effect" and its clinical implications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

Germline mutations in the TP53 gene

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

Inherited p53 gene mutations in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

Constitutional p53 mutation in a non-Li-Fraumeni cancer family

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-8-357

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

Screening for germ line TP53 mutations in breast cancer patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2631588

An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors

31 October 2018

1 reference

12 December 2020

Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years

1 reference

12 December 2020

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium

1 reference

12 December 2020

p53 germline polymorphisms are associated with an increased risk for breast cancer in German women

1 reference

12 December 2020

Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history

1 reference

12 December 2020

A haplotype containing thep53polymorphisms Ins16bp and Arg72Pro modifies cancer risk inBRCA2mutation carriers

1 reference

12 December 2020

Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma

1 reference

12 December 2020

p53 genotypes and haplotypes associated with risk of breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-8-357

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference